All news from Anaesthesiology

Palliative Care A Cancer Patient, Geography May Be Destiny

According to a new study, researchers found striking differences in terminal care across different parts of the country. When it comes to how much end-of-life care a patient with cancer receives, geography may, indeed, be destiny.

The study was published in the Health Affairs, They reveal that in some areas, people with end-stage lung and colorectal cancers received more intensive care and racked up twice as much in spending in the last month of life.

Development of Novel Drugs for Treatment of OUD Encouraged, FDA

The U.S. Food and Drug Administration today issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment (MAT) drugs for the treatment of opioid use disorder (OUD).

The new draft guidance outlines new ways for drug developers to consider measuring and demonstrating the effectiveness and benefits of new or existing MAT products. This new draft guidance is part of the FDA's ongoing commitment to promote more widespread development, access to and adoption of MAT.

Local Anesthetic Given For Pain Relief In Vertebral Fractures

Older patients with one to three recent painful osteoporotic vertebral fractures who had a vertebroplasty or a sham procedure reported similar pain relief over the following year. These results do not support percutaneous vertebroplasty as standard pain treatment in patients with acute osteoporotic vertebral compression fractures. The study was published online in BMJ.

Super-Resolution Microscopy Imaging Of Telomere Structure

Researchers have discovered the role of macromolecular telomere structure in chromosome end protein, with implications for conditions ranging from cancer to aging and heart disease. Telomeres are DNA segments at the ends of every human chromosome. As we age, telomere length naturally decreases. Over the course of a lifetime, telomere shortening instructs aging cells to stop dividing.

Medical Device Approved using Shape Memory Technology

The Food and Drug Administration has approved the use of a medical device in humans for deliberately blocking blood flow to treat bleeding abnormalities or other conditions, a procedure known as embolization. The device integrates expanding shape memory polymer technology that was partly developed at Lawrence Livermore National Laboratory (LLNL).